{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T14:35:16Z","timestamp":1774881316816,"version":"3.50.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.04.069","type":"journal-article","created":{"date-parts":[[2017,8,10]],"date-time":"2017-08-10T10:15:33Z","timestamp":1502360133000},"page":"363-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network"],"prefix":"10.1016","volume":"36","author":[{"given":"Pamela","family":"Bravo-Alc\u00e1ntara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"P\u00e9rez-Vilar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helvert Felipe","family":"Molina-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Sturkenboom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick L.F.","family":"Zuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Maure","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Castro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanesa E.","family":"Castellano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Chiarvetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriana","family":"Falc\u00f3","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Gentile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karina","family":"Guirau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Eugenia P\u00e9rez","family":"Carrega","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susana","family":"Rasjido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sof\u00eda","family":"Testino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Vizzotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Avenda\u00f1o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosanna","family":"Lagos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcelo","family":"Maturana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fernando","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adiela","family":"Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Soza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martha","family":"\u00c1lvarez-Olmos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luz Amparo","family":"Sastoque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcela Hern\u00e1ndez-de","family":"Mezerville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicenta","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ileana","family":"Roverssi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ang\u00e9lica Vargas","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco Tulio","family":"Luque","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liset","family":"Mendoza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renne F. Aquije","family":"Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Esther Castillo","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gladys Turpo","family":"Mamani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo","family":"Giachetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelia","family":"Speranza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Zunino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"35","key":"10.1016\/j.vaccine.2017.04.069_b0005","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1016\/j.vaccine.2013.05.027","article-title":"Roadmap for the international collaborative epidemiologic monitoring of safety and effectiveness of new high priority vaccines","volume":"31","author":"Izurieta","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.04.069_b0010","doi-asserted-by":"crossref","first-page":"B108","DOI":"10.1016\/j.vaccine.2012.10.119","article-title":"Effective vaccine safety systems in all countries: a challenge for more equitable access to immunization","volume":"31","author":"Amarasinghe","year":"2013","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2017.04.069_b0015","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1586\/17512433.2015.1053391","article-title":"Pharmacovigilance in resource-limited countries","volume":"8","author":"Olsson","year":"2015","journal-title":"Exp Rev Clin Pharmacol"},{"key":"10.1016\/j.vaccine.2017.04.069_b0020","unstructured":"Global vaccine safety blueprint. The landscape analysis. WHO\/IVB\/12.04: quality, safety, and standards unit of the Department of Immunizations, Vaccines and Biologicals, World Health Organisation; 2012. <http:\/\/apps.who.int\/iris\/bitstream\/10665\/70854\/1\/WHO_IVB_12.04_eng.pdf>."},{"key":"10.1016\/j.vaccine.2017.04.069_b0025","unstructured":"Global vaccine safety blueprint. WHO\/IVB\/12.07: quality, safety, and standards unit of the Department of Immunization, Vaccines and Biologicals, World Health Organisation; 2012. <http:\/\/extranet.who.int\/iris\/restricted\/bitstream\/10665\/70919\/1\/WHO_IVB_12.07_eng.pdf?ua=1>."},{"issue":"40","key":"10.1016\/j.vaccine.2017.04.069_b0030","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1016\/j.vaccine.2013.06.032","article-title":"International collaboration to assess the risk of Guillain Barre Syndrome following Influenza A (H1N1) 2009 monovalent vaccines","volume":"31","author":"Dodd","year":"2013","journal-title":"Vaccine"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2017.04.069_b0035","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1016\/j.vaccine.2004.01.017","article-title":"Control without separate controls: evaluation of vaccine safety using case-only methods","volume":"22","author":"Farrington","year":"2004","journal-title":"Vaccine"},{"issue":"26","key":"10.1016\/j.vaccine.2017.04.069_b0040","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1016\/j.vaccine.2008.03.074","article-title":"Comparison of epidemiologic methods for active surveillance of vaccine safety","volume":"26","author":"McClure","year":"2008","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2017.04.069_b0045","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/pds.3451","article-title":"A simulation study to compare three self-controlled case series approaches: correction for violation of assumption and evaluation of bias","volume":"22","author":"Hua","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"12","key":"10.1016\/j.vaccine.2017.04.069_b0050","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1017\/S0950268811001531","article-title":"Use of the self-controlled case-series method in vaccine safety studies: review and recommendations for best practice","volume":"139","author":"Weldeselassie","year":"2011","journal-title":"Epidemiol Infect"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2017.04.069_b0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/pds.2330","article-title":"When should case-only designs be used for safety monitoring of medical products?","volume":"21","author":"Maclure","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2017.04.069_b0060","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.publhealth.21.1.193","article-title":"Should we use a case-crossover design?","volume":"21","author":"Maclure","year":"2000","journal-title":"Annu Rev Public Health"},{"issue":"9","key":"10.1016\/j.vaccine.2017.04.069_b0065","doi-asserted-by":"crossref","first-page":"695","DOI":"10.2471\/BLT.14.138875","article-title":"The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level","volume":"92","author":"Maure","year":"2014","journal-title":"Bull World Health Organ"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.069_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/28.1.1","article-title":"Traditional reviews, meta-analyses and pooled analyses in epidemiology","volume":"28","author":"Blettner","year":"1999","journal-title":"Int J Epidemiol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.04.069_b0075","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1542\/peds.2007-1578","article-title":"Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children","volume":"121","author":"France","year":"2008","journal-title":"Pediatrics"},{"issue":"2","key":"10.1016\/j.vaccine.2017.04.069_b0080","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1542\/peds.2011-1111","article-title":"The risk of immune thrombocytopenic purpura after vaccination in children and adolescents","volume":"129","author":"O'Leary","year":"2012","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.vaccine.2017.04.069_b0085","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/adc.84.3.227","article-title":"Idiopathic thrombocytopenic purpura and MMR vaccine","volume":"84","author":"Miller","year":"2001","journal-title":"Arch Dis Child"},{"issue":"1","key":"10.1016\/j.vaccine.2017.04.069_b0090","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.2003.01790.x","article-title":"MMR vaccine and idiopathic thrombocytopaenic purpura","volume":"55","author":"Black","year":"2003","journal-title":"Brit J Clin Pharmacol"},{"issue":"31","key":"10.1016\/j.vaccine.2017.04.069_b0095","doi-asserted-by":"crossref","first-page":"5793","DOI":"10.1016\/j.vaccine.2007.04.058","article-title":"Aseptic meningitis: case definition and guidelines for collection, analysis and presentation of immunization safety data","volume":"25","author":"Tapiainen","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.069_b0100","unstructured":"Mumps virus vaccines. Wkly Epidemiol Rec 2007; 82(7): 51\u201360."},{"issue":"2","key":"10.1016\/j.vaccine.2017.04.069_b0105","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1127\/0941-2948\/2010\/0430","article-title":"Observed and projected climate shifts 1901\u20132100 depicted by world maps of the Koppen-Geiger climate classification","volume":"19","author":"Rubel","year":"2010","journal-title":"Meteorol Z"},{"issue":"15","key":"10.1016\/j.vaccine.2017.04.069_b0110","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1002\/sim.2477","article-title":"Sample sizes for self-controlled case series studies","volume":"25","author":"Musonda","year":"2006","journal-title":"Stat Med"},{"issue":"24","key":"10.1016\/j.vaccine.2017.04.069_b0115","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"49\u201350","key":"10.1016\/j.vaccine.2017.04.069_b0120","doi-asserted-by":"crossref","first-page":"7037","DOI":"10.1016\/j.vaccine.2006.06.049","article-title":"Mumps vaccine virus strains and aseptic meningitis","volume":"24","author":"Bonnet","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.069_b0125","unstructured":"Dengue Laboratory Network of the Americas (RELDA): Pan American Health Organization\/World Health Organization; 2014. <http:\/\/www.paho.org\/hq\/index.php?option=com_content&view=article&id=4497%3A2010-red-laboratorios-dengue-americas-relda&catid=901%3Adengue-program-initiatives&Itemid=39306&lang=en>."},{"key":"10.1016\/j.vaccine.2017.04.069_b0130","unstructured":"About the CLAP\/WR - PAHO\/WHO: Pan American Health Organization\/World Health Organization; 2015. <http:\/\/www.paho.org\/clap\/index.php?option=com_content&view=article&id=24&Itemid=122&lang=en> [updated November 3, 2015]."},{"key":"10.1016\/j.vaccine.2017.04.069_b0135","unstructured":"Oversight of clinical investigations - a risk-based approach to monitoring: US Department of Health and Human Services. Food and Drug Administration; 2013. <http:\/\/www.fda.gov\/downloads\/Drugs\/...\/Guidances\/UCM269919.pdf> [updated August 2013]."},{"issue":"42","key":"10.1016\/j.vaccine.2017.04.069_b0140","doi-asserted-by":"crossref","first-page":"5390","DOI":"10.1016\/j.vaccine.2014.07.073","article-title":"The Vaccine Safety Datalink: successes and challenges monitoring vaccine safety","volume":"32","author":"McNeil","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.04.069_b0145","doi-asserted-by":"crossref","unstructured":"IMPACT after 17 years: lessons learned about successful networking. Paediatr Child Health 2009; 14(1): 33\u20139.","DOI":"10.1093\/pch\/14.1.33"},{"issue":"3","key":"10.1016\/j.vaccine.2017.04.069_b9000","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.vaccine.2017.05.012","article-title":"Enhancing global vaccine pharmacovigilance: Proof-of-concept study on aseptic meningitis and immune thrombocytopenic purpura following measles-mumps containing vaccination","volume":"36","author":"Perez-Vilar","year":"2018","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305613?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17305613?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,25]],"date-time":"2018-06-25T08:39:19Z","timestamp":1529915959000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17305613"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17305613"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.069","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Building capacity for active surveillance of vaccine adverse events in the Americas: A hospital-based multi-country network","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.04.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Pan American Health Organization; licensee Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}